Simply-In-Time Educating (JiTT) lively studying pedagogy utilized by numerous disciplines, however its worth in skilled pharmacy curriculum has not been confirmed.
The purpose of our analysis is to implement and consider this system JiTT (PharmD) Physician of Pharmacy. The impetus in implementing JiTT into PharmD curriculum is to offer college students with the alternative to be taught out-of-classroom to advertise knowledge-based expertise.
The present research summarizes the implementation JiTT in 4 totally different circumstances: two iterations of the required programs “Built-in Microbiology and Virology” (Fall 2016 and Fall 2017) and “Built-in Immunology” (winter 2016-2017 and winter 2017-2018). JiTT together with knowledge-based questions in a a number of alternative format, built-in case research, and the scholars reply earlier than the precise lecture. After the conclusion of every course, college students are requested to give suggestions on JiTT utilization by the use of nameless surveys.
After the Fall of 2016 iterations of Microbiology & Virology course, college students discover an built-in case research to be useful (imply = 3.27 from a most of 4, SD = 0.62), and their total assist JiTT excessive (imply = 3.61 exit 4, SD = 0.50).
Description: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. [UniProt]
Description: Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. [UniProt]
Description: The HTRA2 gene encodes a serine protease. The protein has been localized in the endoplasmic reticulum and interacts with an alternatively spliced form of mitogen-activated protein kinase 14. The protein has also been localized to the mitochondria with release to the cytosol following apoptotic stimulus. The protein is thought to induce apoptosis by binding the apoptosis inhibitory protein baculoviral IAP repeat-containing 4. [RefSeq]
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HtrA2/Omi . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HtrA2/Omi . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HTRA2 / OMI (C-Terminus). This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HTRA2 / OMI (C-Terminus). This antibody is tested and proven to work in the following applications:
Human High temperature requirement protein A 2(HtrA2/Omi)ELISA Kit
Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against HTRA2. Recognizes HTRA2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000
Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against HTRA2. Recognizes HTRA2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against HTRA2. Recognizes HTRA2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IP; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IP:1:200-1:2000
Description: A polyclonal antibody against HTRA2. Recognizes HTRA2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200
Description: A polyclonal antibody against HTRA2. Recognizes HTRA2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC
Research Area: Neuroscience, Signal Transduction, Metabolism, Developmental biology
Description: Antibody raised against HTRA2
For the three different packages which can be included on this research, the first dependent variable is the common worth of scholars from JiTT, rated on a five-point scale. Summing scores from the Fall 2017 iteration of the Built-in Microbiology & Virology course and the second instance of the Immunology course, college students are assessed JiTT very worthwhile (imply = 4.17 of a most of 5, SD = 0.77). scholar performances in JiTT primarily based packages in comparison with non-JiTT primarily based program.
Evaluation of evaluation knowledge on scholar efficiency on the knowledge-based questions present JiTT very useful for scholar studying and JiTT-based programs have a extra constant take a look at scores in comparison with non-JiTT primarily based program. The present outcomes are a promising first step in validating the usefulness JiTT in pharmaceutical packages and lay the groundwork for future research aiming for a direct comparability between the standard lecture model and JiTT pedagogy carried out into PharmD curriculum.
Evaluation of Pupil Perceptions of Simply-In-Time Educating Pedagogy in PharmD Microbiology and Immunology Programs.
Summative evaluation blueprint idea to undergraduate medical college students in microbiology
Background: Evaluation drives studying. written appraisal from many universities don’t have a uniform and validation. subjectivity appraisal affect. The blueprint has been used as a method of content material validity.
Strategies: On this research, Maharashtra final 5-year College of Well being Sciences (MUHS) second 12 months MBBS papers in Microbiology evaluated for validity of its contents. Desired weightage to all of the subjects in microbiology given by the college’s Division of Microbiology. college papers are evaluated for degree of cognitive domains examined. Closed-ended suggestions from college taken and statistically evaluated.
Outcomes: The research revealed the overrepresentation and underrepresentation of many subjects in any respect the final 5 years the college paper with reference to microbiology. Cognitive dimensions examined in accordance query paper Bloom taxonomy revision was solely 8% of the Bloom degree 1, 20% of the extent 2, and eight% of the extent 3, whereas 64% of the questions had been ambiguous. College suggestions revealed a major impact (P <0.05) on blueprints in microbiology.
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: TSPAN9 Antibody: The tetraspan family protein members are characterized by four predicted transmembrane domains and are thought to be involved in physiological processes such as tissue differentiation, immunological responses, and sperm-egg fusion. TSPAN9 has recently been identified as a platelet tetraspanin and a component of tetraspanin microdomains that include the collagen receptor GPVI (glycoprotein VI) and integrin alpha6beta1 but not the von Willebrand receptor GPIbalpha or the integrins alphaIIbbeta3 or alpha2beta1, suggesting that TSPAN9 may act to regulate platelet function in concert with other tetraspanins and their associated proteins.
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: TSPAN9 Antibody: The tetraspan family protein members are characterized by four predicted transmembrane domains and are thought to be involved in physiological processes such as tissue differentiation, immunological responses, and sperm-egg fusion. TSPAN9 has recently been identified as a platelet tetraspanin and a component of tetraspanin microdomains that include the collagen receptor GPVI (glycoprotein VI) and integrin alpha6beta1 but not the von Willebrand receptor GPIbalpha or the integrins alphaIIbbeta3 or alpha2beta1, suggesting that TSPAN9 may act to regulate platelet function in concert with other tetraspanins and their associated proteins.
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TSPAN9. Recognizes TSPAN9 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500
Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against TSPAN9. Recognizes TSPAN9 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TSPAN9 . This antibody is tested and proven to work in the following applications:
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TSPAN9. Recognizes TSPAN9 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TSPAN9. Recognizes TSPAN9 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against TSPAN9. Recognizes TSPAN9 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TSPAN9 (Internal). This antibody is tested and proven to work in the following applications:
)
)
ELISA Kit)
ELISA Kit)
ELISA Kit)
ELISA Kit)
 Antibody)
 Antibody)
)
 Antibody (HRP))
 Antibody (FITC))
 Antibody (Biotin))
 Blocking Peptide)
 Blocking Peptide)
 ELISA Kit)
 ELISA Kit)
 ELISA Kit)
TSPAN5 / NET-4 Peptide 
TSPAN8 Blocking Peptide 
TSPAN9 siRNA 
TSPAN9 Antibody 
Polyclonal TSPAN9 Antibody 
TSPAN9 Polyclonal Antibody 
Human TSPAN9 shRNA Plasmid 
Mouse TSPAN9 shRNA Plasmid  Antibody)
Tetraspanin 9 (TSPAN9) Antibody 
TSPAN9 Antibody, HRP conjugated )
TSPAN9 Recombinant Protein (Rat) 
TSPAN9 Antibody, FITC conjugated )
TSPAN9 Recombinant Protein (Mouse) )
TSPAN9 Recombinant Protein (Human) 
TSPAN9 Antibody, Biotin conjugated  (pORF))
Tspan9 ORF Vector (Rat) (pORF) )
Polyclonal TSPAN9 Antibody (Internal)  (pORF))
TSPAN9 ORF Vector (Human) (pORF)  (pORF))
Tspan9 ORF Vector (Mouse) (pORF)  Antibody (HRP))
Tetraspanin 9 (TSPAN9) Antibody (HRP)  Antibody (FITC))
Tetraspanin 9 (TSPAN9) Antibody (FITC)  Antibody (Biotin))
Tetraspanin 9 (TSPAN9) Antibody (Biotin) 
TSPAN9 Polyclonal Antibody, HRP Conjugated  (pORF))
TSPAN9-IT1 ORF Vector (Human) (pORF) 
TSPAN9 Polyclonal Antibody, FITC Conjugated 
TSPAN9 Polyclonal Antibody, Biotin Conjugated 
Human Tetraspanin- 9, TSPAN9 ELISA KIT 
Mouse Tetraspanin- 9, Tspan9 ELISA KIT ELISA Kit)
Human Tetraspanin 9(TSPAN9)ELISA Kit )
Tspan9 sgRNA CRISPR Lentivector set (Rat) 
Porcine Tetraspanin- 9, TSPAN9 ELISA KIT 
TSPAN9 3'UTR GFP Stable Cell Line 
Tspan9 3'UTR GFP Stable Cell Line )
Tspan9 sgRNA CRISPR Lentivector set (Mouse) )
TSPAN9 sgRNA CRISPR Lentivector set (Human)  (pPM-C-HA))
TSPAN9 Protein Vector (Rat) (pPM-C-HA)  (pPB-C-His))
TSPAN9 Protein Vector (Rat) (pPB-C-His)  (pPB-N-His))
TSPAN9 Protein Vector (Rat) (pPB-N-His)  (pPM-C-His))
TSPAN9 Protein Vector (Rat) (pPM-C-His)  (pPM-C-HA))
TSPAN9 Protein Vector (Human) (pPM-C-HA)  (pPM-C-HA))
TSPAN9 Protein Vector (Mouse) (pPM-C-HA)  (pPB-C-His))
TSPAN9 Protein Vector (Human) (pPB-C-His)  (pPB-N-His))
TSPAN9 Protein Vector (Human) (pPB-N-His)  (pPM-C-His))
TSPAN9 Protein Vector (Human) (pPM-C-His)  (pPB-C-His))
TSPAN9 Protein Vector (Mouse) (pPB-C-His)  (pPB-N-His))
TSPAN9 Protein Vector (Mouse) (pPB-N-His)  (pPM-C-His))
TSPAN9 Protein Vector (Mouse) (pPM-C-His) 
Tspan9 3'UTR Luciferase Stable Cell Line 
TSPAN9 3'UTR Luciferase Stable Cell Line  (Target 1))
Tspan9 sgRNA CRISPR Lentivector (Rat) (Target 1)  (Target 2))
Tspan9 sgRNA CRISPR Lentivector (Rat) (Target 2)  (Target 3))
Tspan9 sgRNA CRISPR Lentivector (Rat) (Target 3)  (Target 1))
Tspan9 sgRNA CRISPR Lentivector (Mouse) (Target 1)  (Target 2))
Tspan9 sgRNA CRISPR Lentivector (Mouse) (Target 2)  (Target 3))
Tspan9 sgRNA CRISPR Lentivector (Mouse) (Target 3)  (Target 1))
TSPAN9 sgRNA CRISPR Lentivector (Human) (Target 1)  (Target 2))
TSPAN9 sgRNA CRISPR Lentivector (Human) (Target 2)  (Target 3))
TSPAN9 sgRNA CRISPR Lentivector (Human) (Target 3)  (pPM-C-HA))
TSPAN9-IT1 Protein Vector (Human) (pPM-C-HA)  (pPB-C-His))
TSPAN9-IT1 Protein Vector (Human) (pPB-C-His)  (pPB-N-His))
TSPAN9-IT1 Protein Vector (Human) (pPB-N-His)  (pPM-C-His))
TSPAN9-IT1 Protein Vector (Human) (pPM-C-His)  (CMV) (pLenti-GIII-CMV))
TSPAN9-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)  (UbC) (pLenti-GIII-UbC))
TSPAN9-IT1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)  (EF1a) (pLenti-GIII-EF1a))
TSPAN9-IT1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) )
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) )
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) )
TSPAN9 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)  (Target 1))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)  (Target 2))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)  (Target 3))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)  (Target 1))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)  (Target 2))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)  (Target 3))
Tspan9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)  (Target 1))
TSPAN9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)  (Target 2))
TSPAN9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)  (Target 3))
TSPAN9 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)  (CMV) (pLenti-GIII-CMV-C-term-HA))
TSPAN9-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)  (CMV) (pLenti-GIII-CMV-GFP-2A-Puro))
TSPAN9-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)  (CMV) (pLenti-GIII-CMV-RFP-2A-Puro))
TSPAN9-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) 
Tspo Peptide 
TSPO Peptide 
TSPYL2 Peptide